Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 19, 2025
Abstract
Dry
eye
disease
(DED)
is
a
multifaceted
ocular
surface
disorder
that
significantly
impacts
patients’
daily
lives
and
imposes
substantial
economic
burden
on
society.
Oxidative
stress,
induced
by
the
overproduction
of
reactive
oxygen
species
(ROS),
critical
factor
perpetuating
inflammatory
cycle
in
DED.
Effectively
scavenging
ROS
essential
to
impede
progression
In
this
study,
boronophenylalanine‐
containing
polydopamine
(PDA‐PBA)
nanoparticles
are
developed
loaded
with
melatonin
(MT),
which
blended
poly(vinyl
alcohol)
(PVA)
create
drops
PVA/
PDA‐PBA@MT
(PPP@MT).
vitro
vivo
studies
demonstrate
PPP@MT
exhibits
dual
functionalities
reducing
production
downregulating
pathways,
thereby
preserving
mitochondrial
integrity
further
inhibiting
programmed
cell
death.
Following
treatment,
tear
secretion,
corneal
structure,
number
goblet
cells
markedly
restored
mouse
model
dry
eye,
indicating
therapeutic
efficacy
agent.
Collectively,
PPP@MT,
characterized
minimal
side
effects
favorable
bioavailability,
offers
promising
insights
for
management
DED
other
ROS‐mediated
disorders.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(18)
Published: March 11, 2024
Polydopamine
nanomaterials
have
emerged
as
one
of
the
most
popular
organic
materials
for
management
oxidative
stress-mediated
inflammatory
diseases.
However,
their
current
anti-inflammatory
ability
is
still
unsatisfactory
because
limited
phenolic
hydroxyl
groups,
and
oxidation
reaction-medicated
reactive
oxygen
nitrogen
species
(RONS)
scavenging.
Herein,
via
fusing
dimension
engineering
surface
charge
engineering,
2D
cationic
polydopamine
nanosheets
(PDA
NSs)
capable
scavenging
multiple
danger
signals
to
enhance
capability
are
reported.
Compared
with
conventional
spherical
nanoparticles,
PDA
NSs
exhibit
three-
fourfold
enhancement
in
RONS
capability,
which
should
be
attributed
high
specific
area
abundant
phenol
groups
ultrathin
structure.
To
further
ability,
polylysine
molecules
absorbed
on
endow
cell-free
DNA
(cfDNA),
another
typical
factor
exacerbate
pathogenesis
inflammation.
Molecular
mechanisms
reveal
that
can
concurrently
activate
Keap1-Nrf2
block
TLR9
signaling
pathway,
achieving
synergistical
inflammation
inhibition.
As
a
proof
concept,
cfDNA
dual-scavenging
effectively
alleviate
bowel
disease
both
delayed
prophylactic
models,
much
better
than
clinical
drug
5-aminosalicylic
acid.
Journal of Inflammation Research,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 5389 - 5413
Published: Aug. 1, 2024
The
intestinal
barrier
maintained
by
various
types
of
columnar
epithelial
cells,
plays
a
crucial
role
in
regulating
the
interactions
between
contents
(such
as
microbiota),
immune
system,
and
other
components.
Dysfunction
mucosa
is
significant
pathophysiological
mechanism
clinical
manifestation
inflammatory
bowel
disease
(IBD).
However,
current
therapies
for
IBD
primarily
focus
on
suppressing
inflammation,
no
disease-modifying
treatments
specifically
target
barrier.
Given
side
effects
associated
with
chronic
immunotherapy,
effective
alternative
that
promote
mucosal
healing
are
highly
attractive.
In
this
review,
we
examined
function
mechanisms
behind
its
disruption
IBD.
We
illustrated
complex
process
proposed
therapeutic
approaches
to
strategies
These
included
application
stem
cell
transplantation
organ-like
tissue
engineering
generate
new
tissue.
Finally,
discussed
potential
restore
treatment
Drug Design Development and Therapy,
Journal Year:
2024,
Volume and Issue:
Volume 18, P. 2921 - 2949
Published: July 1, 2024
Abstract:
Inflammatory
bowel
disease
(IBD)
is
a
chronic,
non-specific
inflammatory
condition
characterized
by
recurring
inflammation
of
the
intestinal
mucosa.
However,
existing
IBD
treatments
are
ineffective
and
have
serious
side
effects.
The
etiology
multifactorial
encompasses
immune,
genetic,
environmental,
dietary,
microbial
factors.
nanoparticles
(NPs)
developed
based
on
specific
targeting
methodologies
exhibit
great
potential
as
nanotechnology
advances.
Nanoparticles
defined
particles
between
1
100
nm
in
size.
Depending
their
size
surface
functionality,
NPs
different
properties.
A
variety
nanoparticle
types
been
employed
drug
carriers
for
treatment
(IBD),
with
encouraging
outcomes
observed
experimental
models.
They
increase
bioavailability
drugs
enable
targeted
delivery,
promoting
localized
thus
enhancing
efficacy.
Nevertheless,
numerous
challenges
persist
translation
from
nanomedicine
to
clinical
application,
including
enhanced
formulations
preparation
techniques,
safety
profiles,
so
forth.
In
future,
it
will
be
necessary
scientists
clinicians
collaborate
order
study
mechanisms,
develop
new
delivery
strategies,
screen
nanomedicines.
Keywords:
nanoparticles,
diseases,
passive
targeting,
active
system
Small Methods,
Journal Year:
2023,
Volume and Issue:
8(7)
Published: Nov. 30, 2023
Abstract
Inflammation‐associated
diseases
are
very
common
clinically
with
a
high
incidence;
however,
there
is
still
lack
of
effective
treatments.
Cell‐biomimetic
nanoplatforms
have
led
to
many
breakthroughs
in
the
field
biomedicine,
significantly
improving
efficiency
drug
delivery
and
its
therapeutic
implications
especially
for
inflammation‐associated
diseases.
Macrophages
an
important
component
immune
cells
play
critical
role
occurrence
progression
while
simultaneously
maintaining
homeostasis
modulating
responses.
Therefore,
macrophage‐biomimetic
not
only
inherit
functions
macrophages
including
inflammation
tropism
effect
targeted
drugs
neutralization
pro‐inflammatory
cytokines
toxins
via
membrane
surface
receptors
or
proteins,
but
also
maintain
inner
nanoparticles.
Macrophage‐biomimetic
shown
remarkable
efficacy
excellent
application
potential
In
this
review,
diseases,
physiological
macrophages,
classification
construction
first
introduced.
Next,
latest
applications
different
treatment
summarized.
Finally,
challenges
opportunities
future
biomedical
discussed.
It
hoped
that
review
will
provide
new
ideas
further
development
nanoplatforms.
Chemistry of Materials,
Journal Year:
2024,
Volume and Issue:
36(12), P. 6114 - 6129
Published: June 3, 2024
Wound
healing
is
a
prolonged
physiological
process
involving
series
of
complicated
biological
responses
influenced
by
various
factors,
such
as
bacterial
infection
and
oxidative
damage.
Existing
treatments,
while
effective,
have
certain
limitations
in
terms
biocompatibility,
responsiveness
to
the
wound
environment,
efficacy
promoting
tissue
regeneration.
To
address
these
shortcomings,
bioinspired
hydration
lubrication
mechanism
articular
cartilage,
we
successfully
designed
developed
an
injectable
situ
photo-cross-linkable
hydrogel,
which
was
synthesized
via
modifying
aminated
hyaluronic
acid
with
polymer
obtained
free
radical
polymerization
o-nitrobenzyl
alcohol
derivative
(NB)
2-methoxyethyl
phosphocholine
(MPC).
The
hydrophilic
layer
formed
around
zwitterionic
charges
MPC
endowed
hydrogel
enhanced
antimicrobial
effects,
whereas
hydroxymethyl
group
NB
enabled
ultraviolet
light-induced
cross-linking
property.
doped
polydopamine
nanoparticles,
facilitated
multifaceted
photothermally
responsive
antibacterial,
anti-inflammation,
angiogenesis.
Specifically,
upon
injection
precursor
solution
into
site
exposure
light,
cross-linked
adhered
closely
skin
tissues,
achieving
hemostasis
exudate
absorption.
Additionally,
showed
excellent
reactive
oxygen
species
scavenging
property,
reducing
cellular
stress
meanwhile
bactericidal
effect
near-infrared
light
irradiation.
Furthermore,
its
networked
porous
structure,
conducive
cell
adhesion
proliferation,
remarkably
enhancing
activity
wound-healing
performances
were
investigated
both
vitro
vivo
experiments,
showcasing
potential
for
treatment
applications,
offering
promising
improvement
over
current
methods
providing
photothermal
responsive,
biocompatible,
effective
process.
Biomacromolecules,
Journal Year:
2023,
Volume and Issue:
24(11), P. 5230 - 5244
Published: Sept. 21, 2023
As
an
acute
ophthalmic
infection,
bacterial
keratitis
(BK)
can
lead
to
severe
visual
morbidity,
such
as
corneal
perforation,
intraocular
and
permanent
opacity,
if
rapid
effective
treatments
are
not
available.
In
addition
eradicating
pathogenic
bacteria,
protecting
tissue
from
oxidative
damage
promoting
wound
healing
by
relieving
inflammation
equally
critical
for
the
efficient
treatment
of
BK.
Besides,
it
is
very
necessary
improve
bioavailability
drugs
enhancing
ocular
surface
adhesion
permeability.
this
investigation,
therefore,
a
synergistic
antibiotic-antioxidant
BK
was
achieved
based
on
multifunctional
block
copolymer
vesicles,
within
which
ciprofloxacin
(CIP)
simultaneously
encapsulated
during
self-assembly.
Due
phenylboronic
acid
residues
in
corona
layer,
these
vesicles
exhibited
enhanced
muco-adhesion,
deep
epithelial
penetration,
bacteria-targeting,
facilitated
drug
delivery
infection
sites.
Additionally,
abundant
thioether
moieties
hydrophobic
membrane
enabled
both
have
ROS-scavenging
capacity
accelerated
CIP
release
at
inflammatory
tissue.
vivo
experiments
mice
model
demonstrated
that
polymer
BK,
owing
bacteria
targeting,
ROS-triggered
release,
combined
antioxidant-antibiotic
therapy.
This
strategy
holds
great
potential
other
diseases
associated
with
infections.